SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing treatments for serious oncological and hematological diseases announced today that it will present at the 13th Annual BIO Asia International Conference taking place March 15-16, 2016 at the Grand Hyatt, Tokyo, Japan. David J. Bearss, Ph.D., Chief Executive Officer, is scheduled to present at 10:00 AM (JST) on Wednesday, March 16, 2016.
